The miniaturization and virtualization processes drive converging technologies from interactions between the NBIC (Nano, Bio, Info, and Cogno) technologies. The converging technologies stimulate innovation, promote research and development in different fields and produce revolutionary progresses in medicine. These technologies enable us to create contacts between brains and machines, the growth in molecular nanotechnology, the construction of respirocytes, chromallocytes, clottocytes, nanorobotic phagocytes, and nanobots. Nanobots would enter the nucleus of a cell and extract all of the genetic material and replace it with a synthetically produced copy of the original that has been manufactured in a laboratory to contain only non-defective base-pairs. It is predicted that “the regenerative medicine”, as a megatrend, will have an enormous effect on medical technologies and clinical sciences. Regenerative medicine is an application field of converging technologies in translational medicine. It attempts to translate the results of tissue engineering to construct 3D tissues and organs. Regenerative medicine is also an exciting field for induced pluripotent stem cell (iPSC) and promises to bring about a paradigm shift to health care. Accumulating evidence indicates that converging technologies will offer great potentials for regenerative medicine to create innovative treatments for diseases that the traditional therapies have not been effective yet.